A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: salivary gland tumor | malignancy
Age: Between 18 - 100 Years
Gender: Male or Female
Individuals at least 18 years of age with Resected High-Risk Malignant Salivary Gland Tumors.
Individuals who have prior systemic chemotherapy or radition therapy for salivary gland malignancy will not be eligible.
Individuals with severe, active co-morbidity, or significant pre-existing hearing loss will not be eligible.
Women who are pregnant will not be eligible.
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required